CFP and hydrops fetalis: To address the mechanism for the decreased properdin levels in HF patients, we examined properdin levels in two different ex vivo models, triggering complement activation in NHS, on solid-phase by zymosan particles9 (Fig. 7b) or in fluid-phase by hemin10 (Fig. 7c).